Navigation Links
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
Date:7/3/2009

and Alzheimer's disease, cancer and physical medicine. This year, the Texas College of Osteopathic Medicine was named a top 50 medical school in primary care by U.S. News & World Report for the eighth consecutive year. "Fort Worth's medical school and more" contributes more than $400 million to the Tarrant County and Texas economies annually. For more information, go to http://www.hsc.unt.edu/.


'/>"/>
SOURCE University of North Texas Health Science Center/Fort Worth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...ewswire/ -- Patients reported C1-esterase inhibito...treating acute swelling attacks at any body locati...ccording to data presented today at the 2009 Ameri...CAAI) Annual Meeting. The results come from a self... with the ongoing, prospective, open label I nter...
(Date:11/6/2009)...re-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC...iously approved reverse split of its common stock ..., Nov. 9, 2009 on a 1-for-15 split-adjusted basis....der the new symbol OXBT. The stock also will have ...comes effective. ,, "This reverse split was ove...
(Date:11/6/2009)...ewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(&...at is developing and marketing Levulan(®) Pho... on patients with common skin conditions, announce...ficer, will present a corporate overview at the Me..., November 10, 2009 at 10:00 a.m. ET at the Hotel ...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Cancer Diagnosis May Tax Physical Mental Health 48369 1Cancer Diagnosis May Tax Physical Mental Health 48369 2Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 1Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 2A real time diagnosis for a treatable cancer 48363 1A real time diagnosis for a treatable cancer 48363 2
... 2007 /PRNewswire-FirstCall/ -- Shire plc,announce...estigational medication guanfacine extended releas...tive,alpha-2A-adrenoceptor agonist. These data fro...ies and two long-term phase III,open-label studies...iation (APA) annual meeting, demonstrated that GXR...
...s from Phase 1 Studies with Monoclonal Antibody,Ta...vide Further,Rationale for IL-9 Inhibition in Deve...d., May 24, 2007 /PRNewswire-FirstCall/ --,MedImmu...highlighting recent progress within the company,s ...rom two Phase 1 clinical,studies with its monoclon...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 T...ak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth an...e for America Act" (H.R. 3962). The amendment main...ding for abortion and for benefits packages that i...th those who receive affordability credits and tho...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 P...a (PhRMA) Senior Vice President Ken Johnson releas...lth care reform bill: ,, "We are disappointed, ... echoed by millions of hardworking Americans as we... of Representatives who voted against the bill. ,...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Working ..., Pa., Nov. 8 On the he... Representatives for a good, balanced health care ... scoring of how our state,s U.S. representatives v...erica Act. ,, The legislation, which passed Sa...
(Date:11/7/2009)..., WASHINGTON , Nov. 7 /PRNewswire-USNewswire/ -...oday in support of H.R. 3962, the Affordable Healt...e legislation later tonight. Below are the Speake...ll know, is an historic moment for our nation and ...ers of every party and political philosophy -- as ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...nd function when enrolled in tailored intervention... Home-based programs to get elderly cancer survivo...mprove their ability to live and function, a new s... a home-based program that sent them tailored prin...
...ientists stress , , TUESDAY, Nov. 18 (Heal...ered a genetic trait that could provide an early i...g cancer. , The research, reported Tuesday at the ...more targeted treatment," said study author Emily ...
...oped by Penn State researchers is proving to be an...rapeutic drugs and the fluorescent dyes that can t... Nano Letters , an interdisciplinary group of mat...ers will successfully enter cells and dissolve har...
...2008 A study appearing in Journal of the America...aries, understanding of their healthcare benefits ...ectively and could lead them to the delay or avoid...f the respondents regarded themselves as being unf...
...dents Dilcia Marinez, Juan Carlos Castaneda and Lu...heir roles in defrauding the Medicare program and ... a $14 million HIV infusion fraud scheme, Acting A...ed. , , Marinez, who pleaded guilty on Sept. ...
...es New Resource So Families of ,Bad, Children Can ... Nov. 18 The holidays should bring peace, harmony... of the season can foster difficult, even disorder...s asking, "What did I do wrong?" , , To help ...
Other Medicine News:Health News:Home-Based Programs Benefit Older Cancer Survivors 2Health News:Genetic Trait Could Predict Lung Cancer 2Health News:Nontoxic nanoparticle can deliver and track drugs 2Health News:Nontoxic nanoparticle can deliver and track drugs 3Health News:Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme 2Health News:Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme 3Health News:Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme 4Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 3
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: